Monday, July 27, 2026
27.3 C
Bengaluru

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief Business Officer – Vaccines. With more than 30 years of leadership experience spanning vaccines, pharmaceuticals, specialty products, and commercial strategy, he brings a strong global perspective and a proven ability to drive growth across diverse markets.

In his new capacity, Manishkumar will oversee the company’s vaccines business across India as well as international markets, including Europe and the United States. His mandate includes enhancing commercial performance, building strategic partnerships, and guiding sustainable business expansion.

Throughout his career, Manishkumar has demonstrated consistent success in scaling operations, strengthening market presence, and delivering measurable results across global healthcare and vaccine markets.

Biological E. looks forward to leveraging his leadership to accelerate growth and strengthen its position in both domestic and international vaccine markets.

MedicinMan congratulates Manishkumar Munot and wishes him continued success in this role.

Hot this week

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Topics

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Meril Life Sciences is India’s Top Medtech Company

India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
spot_img

Related Articles

spot_imgspot_img